Search alternatives:
min decrease » nn decrease (Expand Search), point decrease (Expand Search), gain decreased (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
10 min » 30 min (Expand Search)
min decrease » nn decrease (Expand Search), point decrease (Expand Search), gain decreased (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
10 min » 30 min (Expand Search)
-
241
-
242
Cost-effectiveness and budget impact of immediate antiretroviral therapy initiation for treatment of HIV infection in Côte d’Ivoire: A model-based analysis
Published 2019“…Outcomes from the model included life expectancy, 10-year medical resource use, incremental cost-effectiveness ratios (ICERs) in $/year of life saved (YLS), and 5-year budget impact. We simulated people with HIV (PWH) in care (mean CD4: 259/<i>μ</i>L, SD 198/<i>μ</i>L) and transmitted cases. …”
-
243
-
244
-
245
-
246
-
247
-
248
-
249
-
250
-
251
Flow diagram of the study.
Published 2023“…A total of 162 patients were included. The SOFA score on POD 5 was significantly higher in the High-decrease group compared with the Low-decrease group (5.2 ± 2.6 vs. 4.1 ± 2.3; mean difference: 1.1, 95% CI: 0.3 to 1.8; P = 0.005). …”
-
252
Baseline characteristics of patients.
Published 2023“…A total of 162 patients were included. The SOFA score on POD 5 was significantly higher in the High-decrease group compared with the Low-decrease group (5.2 ± 2.6 vs. 4.1 ± 2.3; mean difference: 1.1, 95% CI: 0.3 to 1.8; P = 0.005). …”
-
253
-
254
-
255
-
256
Delta Kmax<sup>1</sup> with non-accelerated and accelerated CXL<sup>2</sup> protocols.
Published 2022Subjects: -
257
Delta Kmax<sup>1</sup> with epithelium-off and epithelium-on CXL<sup>2</sup> protocols.
Published 2022Subjects: -
258
Meta-analysis of AT (ml/kg/min) and morbidity.
Published 2023“…Using a previously defined cutoff value of > 15mL/kg/min for peak, showed evidence of decreased odds of mortality [OR: 0.55, 95% CI: 0.28–0.81] and but not decreased odds of postoperative morbidity [OR: 0.82, 95% CI: 0.64–1.00]. …”
-
259
Meta-analysis of peak (L/min) and morbidity.
Published 2023“…Using a previously defined cutoff value of > 15mL/kg/min for peak, showed evidence of decreased odds of mortality [OR: 0.55, 95% CI: 0.28–0.81] and but not decreased odds of postoperative morbidity [OR: 0.82, 95% CI: 0.64–1.00]. …”
-
260